Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for UNITED THERAPEUTICS CORP COMMON STOCK (UTHR).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2024.
STATE STREET CORP - 31 Dec 2024 SCHEDULE 13G Report for UNITED THERAPEUTICS CORP COMMON STOCK (UTHR)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- UTHR
- Shares outstanding
- 44,897,837 shares
- Disclosed Ownership
- 2,199,994 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2025, 07:10:41 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 4.9% ownership in UNITED THERAPEUTICS CORP COMMON STOCK (UTHR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 07:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 4.9% | 2,199,994 | 0 | 1,953,795 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |